<DOC>
	<DOCNO>NCT00616694</DOCNO>
	<brief_summary>To evaluate effect subject knowledge disease status persistence subject receive Actonel 5 mg daily 12-month period prevention treatment GIO .</brief_summary>
	<brief_title>Impact Vertebral Fracture Knowledge Persistence Subjects Taking Glucocorticoid Therapy</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Spinal Fractures</mesh_term>
	<mesh_term>Glucocorticoids</mesh_term>
	<mesh_term>Risedronate Sodium</mesh_term>
	<criteria>Subjects variety rheumatologic , pulmonary , skin condition . Subjects oral glucocorticoid mean daily dose great equal 5.0 mg prednisone ( equivalent ) expect ( although require ) remain daily dose great equal 5.0 mg prednisone ( equivalent ) 12 month study start . Women must least one year postmenopausal surgically sterile . Subjects must evaluable BMD site lumbar spine ( LS ) proximal femur . Subject 's unwillingness take Vitamin D , calcium supplement study medication A history cancer : history cancer within past 5 year . Relatively benign skin malignancy , basal cell carcinoma squamous cell carcinoma , exclusion subject remission least 6 month prior enrollment . A history hyperparathyroidism , hyperthyroidism osteomalacia metabolic bone disease within one year prior enrollment History alcohol drug dependence within one year enrollment A history use follow medication within 6 month start study drug : Estrogen estrogenrelated drug ( tamoxifen , raloxifene , tibolone ) ; low dose vaginal estrogen ( estradiol &lt; 0.2 mg/day , estropipate &lt; 1.5 mg/day ) allow , Anabolic steroid , Parathyroid hormone A history use follow medication within 1 month start study drugor 1 month within 6 month prior study entry : Calcitonin , Vitamin D supplement ( &gt; 1000 IU per day ) , Calcitriol ( &gt; 1.5mcg/week ) A history use follow medication within 6 month start study drug 14 day within 1 year prior study entry : Any bisphosphonate , Fluoride ( &gt; 10 mg per day ) , Estrogen implant , Deflazacort Have receive depot injection &gt; 10,000 IU Vitamin D past 12 month Have document history abnormal allergic reaction bisphosphonates History recurrent nephrolithiasis history one episode nephrolithiasis within 5years study entry Severe renal impairment ( creatinine clearance &lt; 30 mL/min ) Subjects steroid therapy transplantation Subjects oral glucocorticoid &gt; 8 week &lt; 6 month screen History hypersensitivity investigational product drug similar chemical structure Clinically relevant cardiovascular , hepatic , neurological , endocrine , major systemic disease make implementation protocol interpretation study result difficult Mental condition render subject unable understand nature , scope , possible consequence study The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2008</verification_date>
</DOC>